Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
131.76%Depreciation and Amortization Margin
VS
Market
Sector
Industry
History
$ 1.3Close
$ 1.09 - $ 16.95 52-Week Range
Ticker Information
Ticker
ERNACompany Name
ERNEXA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQERNEXA THERAPEUTICS INC - Depreciation and Amortization Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ERNA - DepAmor % Historical data
| Date | Depreciation, Amortization & Accretion | Depreciation and Amortization Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 643K | 131.76% | $ 488K |
| 3/31/2025 | $ 1.17M | 217.94% | $ 535K |
| 12/31/2024 | $ 1.64M | 281.44% | $ 582K |
| 9/30/2024 | $ 2.05M | 342.98% | $ 598K |
| 6/30/2024 | $ 2.12M | 1306.79% | $ 162K |
| 3/31/2024 | $ 1.6M | 1393.04% | $ 115K |
| 12/31/2023 | $ 1.12M | 1651.47% | $ 68K |
| 9/30/2023 | $ 728K | 1427.45% | $ 51K |
| 6/30/2023 | $ 332K | 0% | $ 0 |
| 3/31/2023 | $ 421K | 0% | $ 0 |
Key Performance Insights, Last 5 Years
- ERNEXA THERAPEUTICS INC's latest trailing twelve months (TTM) DepAmor % stands at 24.01%.
- Over the past 5 years, ERNEXA THERAPEUTICS INC's average DepAmor % has been 533.94%.
- The median DepAmor % for ERNEXA THERAPEUTICS INC during this period was 217.94%
- ERNEXA THERAPEUTICS INC reached its highest DepAmor % over the past 5 years at 1651.47%.
- The lowest DepAmor % recorded by ERNEXA THERAPEUTICS INC in the same timeframe 24.01%
ERNEXA THERAPEUTICS INC's DepAmor % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
DepAmor % Benchmarks
Similar metrics to Revenues:
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
Definition of Depreciation and Amortization Margin
[Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].DepAmor / Revenues
(=) DepAmor % DepAmor % for ERNEXA THERAPEUTICS INC is calculated as follows: DepAmor [ $ 2.35M ] / Revenues [ $ 9.79M ]
(=) DepAmor % [ 24.01% ] ERNA - Depreciation and Amortization Margin, Last 5 years
24.01%
Minimum
Sep 30, 2020
1651.47%
Maximum
Dec 31, 2023
533.94%
Average
217.94%
Median
DepAmor % Benchmark AnalysisMarket
The chart above depicts the distribution of DepAmor % for companies in the Total Stock Market. The average DepAmor % of the companies is 5.85% with a standard deviation of 5.12%.
The following table provides additional summary stats:
DepAmor % in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | -6.41% |
| max | 22.52% |
| average | 5.85% |
| median | 4.22% |
| std | 5.12% |